Disc Medicine, Inc.
IRON
$77.44
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -23.19% | 13.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.40% | 5.15% | |||
| Operating Income | 6.40% | -5.15% | |||
| Income Before Tax | 6.29% | -4.98% | |||
| Income Tax Expenses | 35.29% | -42.05% | |||
| Earnings from Continuing Operations | 6.25% | -4.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.25% | -4.91% | |||
| EBIT | 6.40% | -5.15% | |||
| EBITDA | 6.41% | -5.16% | |||
| EPS Basic | 6.72% | -2.57% | |||
| Normalized Basic EPS | 6.76% | -4.11% | |||
| EPS Diluted | 6.72% | -2.57% | |||
| Normalized Diluted EPS | 6.76% | -4.11% | |||
| Average Basic Shares Outstanding | 0.50% | 2.28% | |||
| Average Diluted Shares Outstanding | 0.50% | 2.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||